Phase 1 Radiation-induced Xerostomia Clinical Trials

2 recruitingPhase 1

What is a Phase 1 trial?

Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.

Showing 1–2 of 2 trials

Recruiting

Phase 1Phase 2

Study of Circular RNA Treatment in Patients With Radiation Induced Xerostomia-1

Radiation-Induced Xerostomia and Hyposalivation

RiboX Therapeutics Ltd.42 enrolled4 locationsNCT06714253

Recruiting

Phase 1Phase 2

A Randomized Controlled Trial of Spermidine for the Prevention of Radiation-Induced Xerostomia in Head and Neck Squamous Cell Carcinoma (Including Nasopharyngeal Carcinoma)

Radiation-induced Xerostomia

West China Hospital58 enrolled1 locationNCT07035626